Sam Brusco, Associate Editor02.09.22
Philips has expanded the capabilities of its Lumify handheld point-of-care (POC) ultrasound by adding hemodynamic assessment and measurement. The new Pulse Wave Doppler function lets healthcare professionals quantify blood blow in POC cardiology, vascular, abdominal, urology, and obstetrics and gynecology applications. New obstetrics measurements for early gestational age assessment and high-risk pregnancy identification were also added to Lumify.
Beyond 2D and color imaging, Pulse Wave Doppler analyzes hemodynamic patterns to distinguish between arterial and venous blood flow, quantifying hemodynamic function to boost diagnostic confidence and timely decision-making.
Lumify also features advanced analysis software, reporting tools, and live communication with clinicians via tele-ultrasound.
“By applying Philips’ expertise in cardiovascular care, imaging and patient monitoring to Philips Handheld Ultrasound – Lumify – we are committed to deliver a dedicated, innovative point-of-care portfolio, enabling clinicians to quickly assess hemodynamics—including cardiovascular function, organ perfusion and fetal assessment—in a daily routine, to identify abnormalities and intervene quickly,” Philips’ GM of point of care ultrasound Matthijs Groot Wassink told the press. “With the addition of Pulse Wave Doppler and enhanced obstetrics measurements, we have increased the number of markers on which diagnoses can be made, to deliver high quality imaging and enhance the evaluation and effectiveness of treatment in real-time.”
Accprding to Philips, Lumify POC ultrasound is the first tool of its kind with both B-line ultrasound lung imaging quantification software and intelligent heart and lung assessment algorithms. Both are helpful to diagnose and treat pneumonia, a common COVID-19 complication.
Lumify is used in community-based mother and child care programs for underserved communities worldwide, as well. A Philips Foundation program in Kenya is educating midwives to provide ultrasound-based antenatal pregnancy screening in village clinics. Lumify’s telehealth function helps the midwives with virtual radiologist support.
Beyond 2D and color imaging, Pulse Wave Doppler analyzes hemodynamic patterns to distinguish between arterial and venous blood flow, quantifying hemodynamic function to boost diagnostic confidence and timely decision-making.
Lumify also features advanced analysis software, reporting tools, and live communication with clinicians via tele-ultrasound.
“By applying Philips’ expertise in cardiovascular care, imaging and patient monitoring to Philips Handheld Ultrasound – Lumify – we are committed to deliver a dedicated, innovative point-of-care portfolio, enabling clinicians to quickly assess hemodynamics—including cardiovascular function, organ perfusion and fetal assessment—in a daily routine, to identify abnormalities and intervene quickly,” Philips’ GM of point of care ultrasound Matthijs Groot Wassink told the press. “With the addition of Pulse Wave Doppler and enhanced obstetrics measurements, we have increased the number of markers on which diagnoses can be made, to deliver high quality imaging and enhance the evaluation and effectiveness of treatment in real-time.”
Accprding to Philips, Lumify POC ultrasound is the first tool of its kind with both B-line ultrasound lung imaging quantification software and intelligent heart and lung assessment algorithms. Both are helpful to diagnose and treat pneumonia, a common COVID-19 complication.
Lumify is used in community-based mother and child care programs for underserved communities worldwide, as well. A Philips Foundation program in Kenya is educating midwives to provide ultrasound-based antenatal pregnancy screening in village clinics. Lumify’s telehealth function helps the midwives with virtual radiologist support.